Finally we could meet physically at Solstrand hotel after two years. We thank all participants and Trond Mohn Foundation for making it a great event!
Category: News
Gutama Ibrahim – New PhD Student
We welcome Gutama Ibrahim who joins the Michoel group as a PhD student. Gutama has a master degree in Applied Physics and Mathematics from the University of Tromsø. He will work on the project “Intelligent systems for personalized and precise risk prediction and diagnosis of non-communicable diseases”, where he will develop new machine learning methods …
Tobias Rindfleisch – New PhD Student
Meet our new PhD, Tobias Rindfleisch, who will be a member of the Miettinen group at the Department of Chemistry. He will focus on testing and developing molecular dynamics models of intrinsically disordered proteins against NMR relaxation data. Tobias holds MSc in Bioinformatics from University of Potsdam (Germany).
CBU Spring Party
CBU Spring potluck party took place on 31st of March. It has been long since CBU have had a party due to Corona restrictions. It was so nice to be able to gather together with colleagues again. Lots of fun and good food. Ammar is a best dish winner and Pål is a Kahoot winner.
NRC Funding To The Project With Tom Michoel As A Partner
The project “New technologies for target discovery in neuropsychiatric disorders” was selected for funding in the Technological Convergence Related to Enabling Technologies call of the Norwegian Research Council. The project will be led by Jan Haavik with CBU group leader Tom Michoel as a partner. The group of Tom Michoel will be responsible for integrating large-scale …
CBU Leader Eivind Valen – Congratulation On The Grant!
CBU group leader Eivind Valen and Emma Haapaniemi from NCMM got the grant for the project “CRISPR-Cas9 corrected T cells for personalized therapy”. It aims to develop novel methods for personalized gene therapy. Specifically, they will create a computational and clinical CRISPR-Cas9-based editing platform for primary immunodeficiency disease therapy. The project will provide both specific therapies for these diseases …